근거중심한의약 DB
Home > 한의약융합데이터센터 > 근거중심한의약 DBTitle | Qingjin Yiqi granules for post-COVID-19 condition: A randomized clinical trial. |
---|---|
Authors | Pang W, Yang F, Zhao Y, Dai E, Feng J, Huang Y, Guo Y, Zhou S, Huang M, Zheng W, Ma J, Li H, Li Q, Hou L, Zhang S, Wang H, Liu Q, Zhang B, Zhang J. |
Journal | J Evid Based Med. |
Year | 2022 |
Vol (Issue) | 15(1) |
Page | 30-8. |
doi | 10.1111/jebm.12465. |
PMID | |
Url | |
MeSH | COVID-19* / drug therapy |
Keywords | COVID-19; Qingjin Yiqi granules; post-COVID-19 condition; randomized clinical trial; rehabilitation treatment |
한글 키워드 | 코로나19; 청금익기과립; 코로나19 후 증상; 무작위배정 비교임상시험; 재활 치료 |
KMCRIC Summary & Commentary |
|
Korean Study | |
Abstract | Objective: To evaluate the effectiveness and safety of Qingjin Yiqi granules (QJYQ) on post-COVID-19 condition (PCC). |
국문초록 | N |
Language | 영어 |
첨부파일 |